|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 483.9 ILa | -2.02% |
|
-2.93% | +24.72% |
| Mar. 31 | Together Pharma Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Together Pharma Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Together Pharma Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was ILS 31.23 million compared to ILS 12.03 million a year ago. Net loss was ILS 33.52 million compared to ILS 13.78 million a year ago.
Basic loss per share from continuing operations was ILS 4.2 compared to ILS 2.1 a year ago. Diluted loss per share from continuing operations was ILS 4.2 compared to ILS 2.2 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.72% | 11.15M | |
| +20.95% | 8.89B | |
| -10.10% | 5.57B | |
| -18.49% | 1.82B | |
| -25.47% | 1.03B | |
| -15.51% | 939M | |
| -16.02% | 759M | |
| -2.50% | 689M | |
| +7.31% | 231M | |
| -47.66% | 198M |
TOGETHER PHARMA LTD 
